Zecotek Reports the National NanoFab Center Makes Important Progress with the Manufacturing of its MAPD Photo Detector
Singapore, December 21, 2012 – Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today reports that the National NanoFab Center (NNFC) has resolved the most important technological aspects related to the mass production of its upgraded MAPD solid-state photo detector. For the past several years, the positron emission tomography (PET) medical imaging and high-energy physics industries have been progressively revising their requirements for a new class of photo detectors. The demand for timely, cost effective and higher performance PET scanners by the medical sectors as well as the most recent results achieved at CERN, have dictated a challenging upgrade of the photo detector parameters. Zecotek’s versatile and scalable MAPD design and NNFC’s advanced expertise have allowed for the optimization of recovery time for CERN applications and timing resolution for the new PET scanner configurations. NNFC’s immediate next task is to deliver the first new wafers for adoption in Q1 of 2013.
“We have completed the main steps towards a mass scale production of the upgraded MAPD solid-state photo detector that will meet the industries requirements,” said Dr. Boung Ju Lee, Director of CMOS R&BD Division, National NanoFab Center. “Our laboratories are equipped with the most advanced semiconductor and nano-fabrication equipment available and we have dedicated our top engineers to the MAPD manufacturing project. We are impressed with the unique and highly versatile technology of Zecotek’s MAPD solid-state photo detectors and look forward to providing all of the requirements demanded by Zecotek’s varied customers. We expect to deliver the first MAPD wafers in Q1 of 2013.”
“I am very impressed with the ability of the National NanoFab Center to work with our patented technology and our scientific team to resolve the main steps for the large scale manufacturing of the upgraded MAPD, ahead of schedule. ” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “We announced the NNFC would take charge of the development of manufacture of our MAPDs in July 2012, and since that time we have seen significant developments in both high energy physics and PET medical scanning markets. Our relationship with CERN and PET scanner manufactures and designers has become significantly closer. Working with the NNFC scientific team we have optimized the processes for a timely industry adoption.”
Zecotek’s proprietary MAPD-3N is a design upgrade of its previously announced patented MAPD solid-state photo detector and meets all of the challenging industry requirements for new-generation photo detectors used in high energy physics and medical imaging. The Company announced on December 13, 2012 that the COMPASS experiment at CERN had selected the Company’s solid-state MAPD-3N photo detectors, for the multi-purpose experiment in high-energy physics taking place at CERN’s Super Proton Synchrotron accelerator located in Switzerland. The selection of the MAPD-3N is due to its unmatched linearity (dynamic range), photo-detection efficiency, very high radiation hardness and low cost. The Compass experiment as well as the other major CERN experiments, will receive the new upgraded MAPD, optimized for its recovery time, in Q1 of 2013.
– 30 –
About The National NanoFab Center
The National NanoFab Center (NNFC) was founded under Korea’s Nanotechnology Development Promotion Act in May 2004 and has established itself as a leading-edge facility on nano equipment with extensive processing services. The NNFC is ISO 9001 certified and is focused on developing technologies with competitive strength in order to secure a basis for independence by commercializing research outcomes while building capacity for commercialization. Its goal is to develop into a global nanotechnology supporting instituteand center.
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanner technologies, 3D auto-stereoscopic displays, fiber lasers and waveguide micro lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisional companies: Zecotek Imaging (medical, industrial and research), Zecotek Lasers (industrial and research) and Zecotek 3D (monitors for multimedia, entertainment, industrial and medical). The Company has labs located in Canada, Singapore and Russia, with affiliated R&D and production facilities in USA, China, and South Korea. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances with multinational OEMs, distributors and other industry leaders. For more information, visit www.zecotek.com.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Zecotek Photonics Inc.
T: (604) 783-8291
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.